Saturday 17 October 2026
Export YDES’s income statement to Excel — free account
YD Bio Limited
YDES Healthcare Biotechnology
Insiders bought in the last twelve months.
5.92
0.82
−12.17%
Follow YDES
YD Bio Limited (YDES) P/E ratio
P/E ratio, daily
Annual newest first
| Period | P/E ratio | Change |
|---|
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RGNX REGENXBIO Inc. compare | n/m |
| MNPR Monopar Therapeutics Inc. compare | n/m |
| NGNE Neurogene Inc. compare | n/m |
| ALT Altimmune, Inc. compare | n/m |
| CBIO Crescent Biopharma, Inc. compare | n/m |
| ENTX Entera Bio Ltd. compare | n/m |
| ALLO Allogene Therapeutics, Inc. compare | n/m |
| ARVN Arvinas, Inc. compare | 53.6× |
| YDES YD Bio Limited | — |
| Biotechnology industry median | 8.5× |
| Healthcare sector median | 23.0× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)